# A Phase II Trial of Varenicline for the Treatment of Cocaine Dependence

> **NCT01680887** · PHASE2 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 156 (actual)

## Conditions studied

- Cocaine Dependence

## Interventions

- **DRUG:** Varenicline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01680887
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2018-01
- **Final completion:** 2019-06
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2019-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01680887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01680887, "A Phase II Trial of Varenicline for the Treatment of Cocaine Dependence". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01680887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*